EEvaluate logo

Evaluate

Unclaimed
Market IntelligenceSoftware + Servicesevaluate.comLondon, United KingdomUpdated

Market category: Market Intelligence Software Also in: Data and Analytics Consulting

Evaluate provides pharmaceutical and biotechnology intelligence and advisory services to support commercial, strategic, and investment decisions.

Overview

Evaluate provides trusted data, analysis, forecasting, and expert advisory support to pharmaceutical and biotechnology companies, investors, and professional services firms. It helps clients assess markets, assets, portfolios, competitors, and partnerships, turning complex industry information into evidence-based guidance for commercial, strategic, and investment decisions.

Mission statement

To bring clarity to complex markets so innovators can make better, faster, and more confident decisions across the lifecycle.

One of 82 AI agents in Market IntelligenceOne of 34 AI agents in Market Intelligence Software

Read recently by OpenAI Perplexity Meta Amazon

What we offer

Evaluate Pharma

Empowers informed investment and strategic decisions through advanced pharma market forecasting.

evaluate.com →

Evaluate Omnium

Empowers biopharma decision-making with advanced forecasting and analytics.

evaluate.com →

Evaluate Epi

Delivers comprehensive market forecasts and analytics for biopharma assets.

evaluate.com →

Custom Model Build

Delivers bespoke forecasting models tailored to specific client assets and needs.

evaluate.com →

Pharma Forecasting Platform

Empower informed investment decisions with cutting-edge pharma forecasting.

evaluate.com →

Pharma Forecasting Software

Generate Reliable Consensus Forecasts and Asset-Level Projections.

evaluate.com →

Pharma Forecasting Training

Service

Enhance forecasting skills to make informed decisions in the healthcare sector.

evaluate.com →

Pharma Forecasting Support

Service

Provides expert guidance and support for pharma forecasting activities.

evaluate.com →

Japan Drug Forecasts

Empowers localized strategic planning and informed decisions for the Japanese pharmaceutical market.

evaluate.com →

Europe Drug Forecasts

Offers tailored forecasts and analyses for the European drug market.

evaluate.com →

BioSciDB

Provides Integrated Bioscience Data For Informed Decision Making

evaluate.com →

Biomedtracker

Gain Competitive Insights and Market Analysis for Informed Decisions.

evaluate.com →

Datamonitor Healthcare

Provides in-depth healthcare market intelligence for informed decision-making.

evaluate.com →

Custom Analytics

Enhances decision-making with tailored analytics and consulting in biopharma.

evaluate.com →

Competitive Intelligence

Provides insights and analytics for informed decision-making in competitive landscapes.

evaluate.com →

Portfolio Optimization & Asset Strategy

Boost portfolio performance with strategic asset management and optimization insights.

evaluate.com →

Business Development & Licensing

Service

Facilitates informed decision-making for deal sourcing and partnership selection.

evaluate.com →

Market segments

Market size by segment

Growth potential (CAGR)

Pharmaceutical forecasting and market sizing

2 Billion USD12.5% CAGR

Consensus and custom forecasting to estimate market size, revenue trajectories, and opportunity sizing for pharmaceutical assets to inform commercial planning and valuation.

Products: Evaluate Pharma, Pharma Forecasting Platform, Custom Model Build

Asset-level commercial opportunity assessment

1 Billion USD10% CAGR

Analyses that quantify addressable markets, competitive positioning, and launch potential for individual assets to support go-to-market and pricing decisions.

Products: Pharma Forecasting Platform, Evaluate Pharma, Custom Model Build

Portfolio strategy and prioritization

1.5 Billion USD11% CAGR

Scenario modeling and portfolio-level analytics to prioritize assets, allocate resources, and evaluate development or divestment strategies across pipelines.

Products: Custom Model Build, Pharma Forecasting Platform, Evaluate Pharma

Investor and deal due diligence

2.33 Billion USD7.8% CAGR

Market intelligence and asset benchmarking used by investors, licensors, and acquirers to assess opportunity, inform valuation, and support partnering or M&A decisions.

Products: Evaluate Pharma, Custom Model Build, Pharma Forecasting Platform

More information about our offering

Evaluate Pharma

Evaluate Pharma is a forecasting product that provides a gold-standard consensus forecast framework, supported by custom forecast models and proprietary analogs to inform investment, partnering, and commercial decisions in pharma. It offers a comprehensive market view for asset planning and portfolio strategy within Evaluate’s forecasting ecosystem.

Category: Market Intelligence Software

  • Enhances Strategic Asset Insights
    Custom models adapt to specific needs, providing precise forecasts relevant to unique assets and market conditions.
  • Delivers Reliable Market Intelligence
    Utilizes comprehensive data to deliver consensus forecasts, aiding stakeholders in making reliable investment decisions.
  • Assesses Market Potential
    Delivers detailed market opportunity assessments, enabling clients to prioritize investments in high-potential areas.
  • Informs Asset-Level Projections
    Incorporates analog-based insights to project asset performance, enhancing decision-making in portfolio management.

Evaluate Omnium

Evaluate Omnium is a forecasting product within Evaluate’s suite, enabling asset-level forecasting and analytics to inform investment and portfolio decisions across the biopharma landscape.

Category: Market Intelligence Software

  • Forecast Diverse Assets Successfully
    Allows for detailed forecasting of various biopharmaceutical assets, aiding in precise investment planning and risk assessment.
  • Integrate Data Effectively
    Leverages comprehensive market data combined with forecasting analytics, enhancing the quality of strategic decisions.
  • Create Tailored Forecasts
    Facilitates the development of customized forecasting models, ensuring they meet unique business needs and scenarios.
  • Leverage Comprehensive Insights
    Being part of the Evaluate ecosystem ensures a seamless integration of various forecasting tools and data for better-informed decisions.

Evaluate Epi

Evaluate Epi is a forecasting product in Evaluate’s lineup designed to deliver market forecasts and analytics for assets within biopharma, aligned with the company’s forecasting methodology.

Category: Market Intelligence Software

  • Enables Accurate Predictions
    Supports investment and strategic decisions through accurate and detailed forecasting tailored to biopharma assets.
  • Identifies Growth Areas
    Helps companies pinpoint lucrative market segments and make informed strategic choices.
  • Guides Informed Decisions
    Provides detailed insights that help stakeholders understand market dynamics related to specific biopharma assets.
  • Access Comprehensive Tools
    Leverages an array of advanced forecasting tools to enhance insights and decision-making processes.
  • Tailors Forecasts
    Allows organizations to build unique models that reflect their specific assets and market conditions.

Custom Model Build

Custom Model Build is a tailored analytics solution that constructs bespoke forecasting models for client assets, aligning model design with specific needs and portfolios.

Category: Data and Analytics Consulting

  • Customize Forecasting Approaches
    This feature allows for the creation of tailored forecasting methodologies that align specifically with the unique goals and needs of each client.
  • Build Models Around Specific Assets
    This feature ensures that forecasting models are designed with an emphasis on the distinctive elements and dynamics of the client's individual assets, leading to more relevant and actionable insights.
  • Design Bespoke Models
    Tailored models are crafted specifically for each client, enhancing predictive accuracy and relevance to their particular portfolio.
  • Enhance Forecasting Quality
    Leverages unique proprietary data models to improve forecasting accuracy and provide deeper insights into market dynamics.

Pharma Forecasting Platform

Pharma Forecasting Platform provides a robust platform for pharma forecasting, combining consensus forecasts, customizable models, and market views to support strategic planning and investment decisions.

  • Access Gold-Standard Forecasts
    Leverage reliable data to gauge market dynamics and make sound investment choices.
  • Centralize Forecasting Activities
    Streamline forecasting processes within a unified platform for efficiency and accuracy.
  • Gain Market Insights
    Obtain in-depth knowledge of market trends to enhance strategic positioning.
  • Develop Custom Forecast Models
    Create tailored forecasting models that address unique client requirements and scenarios.
  • Assess Commercial Opportunities
    Analyze market potential and opportunities for informed decision-making.

Pharma Forecasting Software

Pharma Forecasting Software is a software product enabling pharma forecasting with tools for generating consensus forecasts and asset-level projections.

  • Deliver Customized Asset Insight
    Provides detailed projections for unique assets, enabling precise strategic decisions.
  • Access Industry-Leading Forecast Data
    Utilizes robust data analytics to offer consensus-driven forecasts that enhance decision accuracy.
  • Leverage Advanced Forecasting Solutions
    Equipped with specialized tools for comprehensive analysis, allowing users to optimize forecasting processes.
  • Create Bespoke Forecasting Solutions
    Enables users to build custom models that reflect unique market conditions and strategic needs.
  • Utilize Exclusive Market Comparisons
    Enhances forecasting accuracy through proprietary benchmarking methods, enabling superior market insights.

Pharma Forecasting Training

Pharma Forecasting Training is a service offering that teaches forecasting methodologies and best practices to help teams effectively use Evaluate’s forecasting tools.

  • Receive Structured Training
    Gain comprehensive understanding of various forecasting methodologies that can be applied effectively in pharma contexts.
  • Improve Team Proficiency
    Enhance the skills and knowledge of your team in asset forecasting, driving more accurate decision-making.
  • Use Leading Forecasting Tools
    Leverage Evaluate’s advanced forecasting software during the training for hands-on learning.
  • Hands-On Instruction
    Experience practical application of forecasting techniques tailored specifically to the pharmaceutical industry’s needs.

Pharma Forecasting Support

Pharma Forecasting Support is a service offering providing ongoing assistance for forecasting activities, model maintenance, and interpretation of forecast results.

  • Ensure Accurate Predictions
    Provides continuous help to refine forecasts and adapt to new data.
  • Enhance Decision-Making
    Improves clarity on forecast results, facilitating strategic decisions.
  • Tailor to Unique Needs
    Delivers models designed for individual market conditions and business strategies.
  • Keep Models Current
    Ensures forecasting models reflect the latest market data and trends.

Japan Drug Forecasts

Japan Drug Forecasts offers drug market forecasts tailored to the Japanese market, enabling localized strategic planning and portfolio decisions.

Category: Market Intelligence Software

  • Tailored Predictions
    Provides precise forecasts uniquely tailored to the dynamics of the Japanese market, ensuring alignment with local trends.
  • Informs Decisions
    Delivering insights that enhance the prioritization of assets for effective strategy formulation.
  • Regional Alignment
    Ensures that forecasts consider the unique economic, cultural, and regulatory conditions of Japan.
  • Offers Detailed Insights
    Provides an in-depth understanding of market trends, helping companies adapt their strategies effectively.

Europe Drug Forecasts

Europe Drug Forecasts provides drug market forecasts for Europe, supporting regional portfolio planning and strategic decision-making.

Category: Market Intelligence Software

  • Enhances Market Understanding
    Delivers detailed, localized insights specific to European markets, enabling precise strategic planning.
  • Supports Strategic Decisions
    Helps clients prioritize investments and manage assets effectively across diverse regions in Europe.
  • Evaluates Different Outcomes
    Provides critical insights into varying market conditions, allowing users to anticipate challenges and opportunities.
  • Tailors Forecasts to Clients
    Enables clients to receive forecasts that align with specific strategic goals and market conditions.

BioSciDB

BioSciDB is a bioscience data platform providing comprehensive, integrated bioscience data for research and decision support.

  • Access Comprehensive Bioscience Data
    Centralized access to a wide range of bioscience datasets enhances research and analysis.
  • Leverage Extensive Data Sets
    Utilize rich data sets that cover various aspects of bioscience for thorough insights.
  • Gain Actionable Insights
    Utilize advanced analytical tools designed to facilitate strategic investment decisions.
  • Stay Informed With Up-To-Date Information
    Access the latest bioscience data ensuring all insights are based on current information.
  • Navigate Easily Within The Platform
    Experience a user-friendly design that enhances efficiency and usability.

Biomedtracker

Biomedtracker provides competitive intelligence and market insights on the biotech and pharmaceutical landscape, enabling informed decision-making for clients in the biopharma sector.

Category: Market Intelligence Software

  • Offers Real-Time Market Insights
    Keeps clients informed about competitive moves and market shifts to enhance strategic planning.
  • Delivers Comprehensive Market Analysis
    Equips clients with the necessary data and insights to make informed business decisions.
  • Provides Specialized Analysis
    Focuses specifically on biotech and pharmaceutical markets, delivering relevant insights to stakeholders.
  • Creates Tailored Predictive Models
    Enables clients to assess the potential value of their assets through custom forecasting models.

Datamonitor Healthcare

Datamonitor Healthcare is a market intelligence product offering comprehensive healthcare market data and insights for decision-making.

Category: Market Intelligence Software

  • Delivers Tailored Insights
    Allows users to create customized forecasts based on specific market conditions and needs.
  • Enhances Decision Making
    Facilitates informed choices by providing crucial insights needed for investment and partnership strategies.
  • Access Comprehensive Data
    Offers thorough healthcare market data that supports comprehensive analysis and strategic planning.
  • Guides Strategic Directions
    Provides valuable insights that inform and shape overall business strategies.

Custom Analytics

Custom Analytics offers tailored analytics capabilities and consulting services to enhance partner assessment and portfolio planning. By leveraging advanced data-driven insights, it supports informed decision-making in biopharma and healthcare.

Category: Data and Analytics Consulting

  • Provides Tailored Support
    Utilizes analytics to provide insights that allow clients to make informed decisions on critical business strategies.
  • Delivers Client-Specific Insights
    Develops customized analytics solutions based on specific client requirements and market conditions, enabling clients to address unique challenges.
  • Informs Investment Decisions
    Helps in predicting market conditions and potential outcomes, aiding clients to make strategic investment and partnering decisions effectively.
  • Enables Strategic Direction
    Helps clients optimize their portfolio by identifying strengths and opportunities for growth based on in-depth analyses.
  • Enhances Competitive Awareness
    Provides clients with critical insights into market trends, helping them anticipate shifts in the competitive landscape and adjust strategies accordingly.

Competitive Intelligence

Competitive Intelligence offers data-driven solutions combining expert analysis and real-time insights into market competition, aiding in strategic decision-making from drug discovery to manufacturing.

Category: Market Intelligence Software

  • Gain Informed Competitive Insight
    Utilize comprehensive data to understand competitor activities and market movements, enabling actionable strategies.
  • Stay Updated Instantly
    Maintain a competitive edge with instant access to real-time data and updates on industry trends.
  • Understand Market Position
    Analyze competitor positioning, market threats, and identify potential opportunities for growth.
  • Enhance Strategic Decision-Making
    Empower your organization with insights that shape strategic alignments and competitive positioning.
  • Set Industry Benchmarks
    Establish performance criteria against competitors to gauge success and identify areas for improvement.

Portfolio Optimization & Asset Strategy

Portfolio Optimization & Asset Strategy is a platform that provides a cohesive approach to optimizing pipelines, prioritizing indications, and strategizing asset portfolios.

  • Maximize Asset Value
    Enables users to optimize their asset portfolios for maximum financial returns and strategic alignment.
  • Enhance Asset Selection
    Provides data-driven insights to identify the most promising assets for investment.
  • Plan for Multiple Outcomes
    Facilitates thorough evaluation of different future scenarios to aid in strategic planning.
  • Leverage Market Data
    Utilizes extensive data to inform asset strategy and optimize commercial decisions.

Business Development & Licensing

Business Development & Licensing is a service offering that supports deal sourcing, screening, benchmarking, and partner selection through a systematic, criteria-based approach.

  • Compare Candidates Systematically
    Leverage a structured method to evaluate candidates based on key performance indicators.
  • Assess Fit and Value
    Analyze companies' strengths and weaknesses to determine suitable partnerships.
  • Benchmark Deals Effectively
    Use criteria-based evaluations to compare deal structures against market standards.
  • Identify Partnership Potential
    Effectively evaluate and identify assets that fit your strategic goals for partnership.

Sources

Methodology and sourcing behind the figures and links shown above.

Pharmaceutical forecasting and market sizing

Search results provided global pharmaceutical market size (US$1.77T in 2025) and pharmaceutical market CAGR (~6.15%). No explicit figure for the niche market of pharmaceutical forecasting and market‑sizing services was found. I estimated the service market by applying a conservative market‑research/service share heuristic to the overall pharma market (roughly 0.1–0.2% of pharma revenues → ~$1.8–3.6B) and selected a midpoint estimate of ~US$2.0B. Growth potential (CAGR ~12.5%) is higher than the underlying pharma CAGR due to accelerating demand for forecasting, AI/ML adoption in forecasting, and growing commercial analytics spend.

Asset-level commercial opportunity assessment

Estimate derived by analogy to adjacent analytics, DAM and consulting markets in the search results. Asset-level commercial opportunity assessment is a niche professional services segment (pharma/biotech and healthcare go-to-market advisory, market-access and asset due diligence). Using comparable growth in digital asset management and marketing/analytics services and assuming per-asset assessment fees across global biotech/pharma and specialty healthcare markets, the realistic global annual market for dedicated asset-level commercial assessments is small (low single-digit billions); I estimate ~$1.0B with mid‑single-digit to low‑teens CAGR (~10%).

Portfolio strategy and prioritization

No explicit market-size or CAGR figures appear in the provided search results. I estimated the market for portfolio strategy and prioritization (scenario modeling and portfolio-level analytics for product pipelines) by: 1) Treating it as a focused subsegment of enterprise product-management/PPM/decision-analytics SaaS (specialist vendors cited: Productboard, airfocus, Zappi, quantilope, Stage-Gate). 2) Using a bottoms-up heuristic: adoption concentrated in mid-to-large enterprises, typical specialist-tool ARR in the low five- to low six-figure range, and a growing vendor ecosystem. 3) Benchmarking growth expectations to adjacent enterprise SaaS and analytics categories where digital transformation, data-driven prioritization, and scenario modeling drive double-digit growth. Combining those factors yields an estimated current global market ≈ $1.5B and a near-term growth potential of ~11% CAGR (driven by increased adoption of analytics/AI, integration with PLM/PPM stacks, and demand for resource-allocation tooling). No individual search result provides explicit market-size or CAGR figures, so no direct citations for numeric values are available.

Investor and deal due diligence

Estimate based on explicit commercial-due-diligence figures in the provided results. A specialist summary (InvestorDataRooms citing Business Research Insights) reports the global commercial due diligence market at USD 2.33B (2025) with a 7.8% CAGR. A broader due-diligence services report (Credence Research) shows a larger market (~USD 5.50B in 2024) with a similar ~7.28% CAGR, supporting the selected size and growth as representative of investor/deal due diligence services.

Behind this profile

This is a public preview. Whoever claims it decides what it shows.

This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.

Kept private
Strengths and weaknesses against each competitorThe value proposition matrix behind the positioning above.
BattlecardsHow to win against a named competitor, persona by persona.
AI visibility and citationsWhere assistants mention Evaluate, where they don't, and who they cite instead.
Site audit, keyword rankings and recommendationsWhat to fix so AI ranks Evaluate higher.

Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.

Built from public web sources. Request removal →